MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
160 hedge funds and large institutions have $962M invested in Momenta Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 43 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% more funds holding
Funds holding: 155 → 160 (+5)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
160
Holding in Top 10
–
Calls
$1.76M
Puts
$53K
Top Buyers
| 1 | +$44.4M | |
| 2 | +$10.9M | |
| 3 | +$9.03M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$4.97M |
| 5 |
SC
Samlyn Capital
New York
|
+$3.97M |
Top Sellers
| 1 | -$8.24M | |
| 2 | -$6.96M | |
| 3 | -$6.93M | |
| 4 |
SAM
Senzar Asset Management
New York
|
-$6.47M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$5.54M |